ChemoCentryx
CCXI
#3564
Rank
NZ$6.43 B
Marketcap
NZ$89.53
Share price
0.00%
Change (1 day)
33.61%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.43 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.43 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
NZ$44.85 B 596.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$685.36 B 10,543.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.12 B 2,526.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
NZ$179.53 B 2,688.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$856.94 B 13,208.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$292.45 B 4,441.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$252.42 B 3,820.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$58.87 B 814.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
NZ$419.90 B 6,421.18%๐Ÿ‡บ๐Ÿ‡ธ USA